Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Cytek Biosciences (CTKB)
NASDAQ:CTKB
Holding CTKB?
Track your performance easily
CTKB Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$3.80 - $9.87
Previous Close$5.06
Volume181.62K
Average Volume (3M)689.87K
Market Cap
$695.66M
Enterprise Value$397.65M
Total Cash (Recent Filing)$277.21M
Total Debt (Recent Filing)$9.44M
Price to Earnings (P/E)―
Beta1.46
Next Earnings
Nov 05, 2024EPS Estimate
$0.02Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.13
Shares Outstanding131,505,592
10 Day Avg. Volume743,850
30 Day Avg. Volume689,872
Standard Deviation0.19
R-Squared0.12
Alpha-0.03
Financial Highlights & Ratios
Price to Book (P/B)1.71
Price to Sales (P/S)3.55
Price to Cash Flow (P/CF)28.30
P/FCF Ratio35.10
Enterprise Value/Market CapN/A
Enterprise Value/Revenue2.01
Enterprise Value/Gross Profit3.63
Enterprise Value/Ebitda-44.78
Forecast
1Y Price Target
$9.00Price Target Upside70.13% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
Cytek Biosciences News
Bulls Say, Bears Say
Bulls Say
Financial PerformanceThe company reiterated guidance of FY24 positive cash flow from operations.
International GrowthCTKB saw strong growth within international markets and service revenue.
Long-term Growth DriversConfidence in long-term growth drivers intact as spectral flow approach replaces traditional instruments in the US.
Bears Say
Earnings GuidanceFY24 net income guide was lowered.
Financial PerformanceCTKB posted Q2 revenues of $46.6M, missing the Street estimate by $2.9M, largely due to persistent US instrument market weakness.
Market RecoveryMarket recovery is not on pace with management's expectations.
---
Ownership Overview
19.21% Insiders
17.31% Mutual Funds
36.32% Other Institutional Investors
27.16% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
CTKB FAQ
What was Cytek Biosciences’s price range in the past 12 months?
Cytek Biosciences lowest stock price was $3.80 and its highest was $9.87 in the past 12 months.
What is Cytek Biosciences’s market cap?
Currently, no data Available
When is Cytek Biosciences’s upcoming earnings report date?
Cytek Biosciences’s upcoming earnings report date is Nov 05, 2024 which is in 46 days.
How were Cytek Biosciences’s earnings last quarter?
Cytek Biosciences released its earnings results on Aug 06, 2024. The company reported -$0.026 earnings per share for the quarter, missing the consensus estimate of -$0.003 by -$0.023.
Is Cytek Biosciences overvalued?
According to Wall Street analysts Cytek Biosciences’s price is currently Undervalued.
Does Cytek Biosciences pay dividends?
Cytek Biosciences does not currently pay dividends.
What is Cytek Biosciences’s EPS estimate?
Cytek Biosciences’s EPS estimate is $0.02.
How many shares outstanding does Cytek Biosciences have?
Cytek Biosciences has 131,505,580 shares outstanding.
What happened to Cytek Biosciences’s price movement after its last earnings report?
Cytek Biosciences reported an EPS of -$0.026 in its last earnings report, missing expectations of -$0.003. Following the earnings report the stock price went down -9.431%.
Which hedge fund is a major shareholder of Cytek Biosciences?
Among the largest hedge funds holding Cytek Biosciences’s share is Deerfield Management Company, LP. It holds Cytek Biosciences’s shares valued at 869K.
---
Cytek Biosciences Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$9.00 (70.13% Upside)
$9.00 (70.13% Upside)
Blogger Sentiment
Bullish
CTKB Sentiment 100%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Decreased
By 6.6M Shares
Last Quarter.
Last Quarter.
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-24.36%
12-Months-Change
Fundamentals
Return on Equity
-4.32%
Trailing 12-Months
Asset Growth
-7.87%
Trailing 12-Months
Company Description
Cytek Biosciences
Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Aurora and Northern Lights systems, are the first full spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells.
---
CTKB Earnings Call
Q2 2024
0:00 / 0:00
---
CTKB Stock 12 Month Forecast
Average Price Target
$9.00
▲(70.13% Upside)
Technical Analysis
Best Analysts Covering CTKB
1 Year
1 Year Success Rate
2/18 ratings generated profit
1 Year Average Return
-25.09%
assigned a buy rating 16 days ago
Copying David Westenberg's trades and holding each position for 1 Year would result in 11.11% of your transactions generating a profit, with an average return of -25.09% per trade.
---